Clinical Trial: Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
Brief Summary: To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prevention of oral candidiasis in patients with AIDS or AIDS related complex (ARC) (group III or IV, CDC classification).
Detailed Summary:
Sponsor: Bristol-Myers Squibb
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Bristol-Myers Squibb
Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: October 1, 2007
Last Verified: October 2007